·The Hindu·15 marks·250–350 wordsPolityEconomyS&T

Robust disease surveillance is a precondition for credible health targets. Discuss in the context of the WHO Global TB Report 2026's treatment of India's incidence estimates.

New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →
In this answer
  1. Why surveillance is a precondition for credible targets
  2. What the WHO report's treatment of India reveals
  3. Way forward

India aimed to eliminate TB by 2025, five years ahead of the SDG 3.3 deadline. The NSP 2017–2025 planned to cut incidence from 217 to 43 per lakh [1]. But the WHO Global TB Report 2026 held back India's 2025 incidence estimate "pending an assessment of new surveillance data" [1]. A target is only as credible as the data that measures it.

Why surveillance is a precondition for credible targets

  • Stable baseline: Later estimates put India's 2015 incidence at 237 per lakh [3], not the NSP's 217 [1]. The starting line moved while the target stayed fixed.
  • Notification is not incidence: India notified a record 25.3 lakh cases in 2025 [1]. More notified cases may mean better case-finding, not less transmission.
  • Hidden cases: The 100-day campaign found 2.85 lakh asymptomatic patients among 7.19 lakh detected [4]. A system that waits for patients with symptoms misses these cases.
  • Global accountability: About 10.6 million people developed TB in 2025 [2]. India carries nearly a quarter of that burden [1], so its data shapes how the world tracks End TB progress.

What the WHO report's treatment of India reveals

  • Positive: WHO insisting on checked field data rather than modelling alone makes future claims more credible.
  • Clear gains where data are reliable: TB deaths fell 38% (28 to 18 per lakh) since 2015 [1].
  • Concern: With no estimate for the target year, India can neither prove nor disprove success. Incidence was still 187 per lakh in 2024 [3], far above 43.
  • Blind spots: Missed patients are concentrated in the private sector, the urban poor and remote areas [1], which is an equity gap.

Way forward

  • Year-round active case-finding, with X-ray screening of high-risk groups instead of one-off campaigns [4].
  • Enforce private-sector notification on the Ni-kshay portal.
  • Hold regular sub-national prevalence surveys, and publish their methods so WHO can check them.
  • Ring-fence surveillance budgets, since domestic sources now fund 86% of TB spending [1].

Surveillance is the foundation that makes health targets checkable, not a technical afterthought. India's next TB plan should pair ambition with independent, transparent data and yearly milestones. That would turn a missed deadline into credible progress towards SDG 3.3 by 2030.

Sources

  1. 1India missed its 2025 TB elimination target. What does the WHO report show? — The Hindu, 19 Nov 2026 (news explainer)NSP target of 217 to 43 per lakh; WHO holding back India's 2025 estimate; 25.3 lakh notifications; 38% fall in deaths; quarter of global burden; missed private-sector and remote patients; 86% domestic funding
  2. 2WHO Global Tuberculosis Report 2026about 10.6 million people developed TB worldwide in 2025
  3. 3PIB (MoHFW): TB incidence in India falls from 237 per lakh (2015) to 187 per lakh (2024)revised 2015 baseline; 2024 incidence
  4. 4PIB: PM reviews status and progress of TB Mukt Bharat Abhiyaan100-day campaign: 7.19 lakh cases detected, 2.85 lakh of them asymptomatic
Practice
8 questions on this article
Check the answer for each question, or reveal all at once.
Practice MCQs →

More from this note

More on Polity